Pharmaceutical Glaze.

Talc is dusted or suspended with shellac glaze as the anti-tacking solid that stops freshly glazed tablets from sticking. The pairing is one of the oldest in tablet finishing.

Beeswax is applied over or with shellac glaze as the polishing wax that gives the final gloss and reduces surface tack. Glaze supplies the seal, wax supplies the shine.

Bleached beeswax is the polishing grade chosen when the finished tablet is light coloured and yellow wax would tint it. It performs the same gloss and anti-tack role over the glaze layer.

Yellow beeswax is buffed over a shellac glaze to seal micro-cracks and raise the gloss of the finished surface. It is the traditional partner for confectioner's glaze.

A hypromellose subcoat is often laid down first to smooth the core and give the shellac glaze an even surface to bond to. Layering the two avoids the mottling that glaze alone can show on a rough core.

Shellac lays down a hard, brittle film with a matte to semi-gloss finish, and carnauba wax is buffed over it to produce the high-gloss surface consumers associate with a coated tablet. The wax also reduces tackiness during handling and packaging. This is standard tablet-coating practice and needs no trial to state.

Shellac films are transparent to translucent, so an opacifier is dispersed in the coating solution when the core needs to be hidden or protected from light. Titanium dioxide is the conventional choice for that role. Its function is optical and it does not change the dissolution behaviour of the resin.

Shellac becomes tacky during the drying phase of a coating run, and tablets stick to one another in the pan. Stearic acid or a stearate is added as an anti-tack aid so the bed keeps moving. The role is entirely process-side.

Magnesium stearate is used as an anti-tack and flow aid in coating and compression steps. Because shellac's film behaviour depends on free carboxylic acid groups, an alkaline stearate in prolonged contact can partly neutralise them and shift the pH at which the film dissolves. Formulators account for that rather than ignoring it.

Ethylcellulose is insoluble across the gastrointestinal pH range and controls release by diffusion, while shellac controls it by pH-dependent ionisation. Blending the two gives a film whose behaviour is set by both variables. This is well established polymer coating science.

Alginate is soluble at intestinal pH and gels at gastric pH, which is a partly complementary behaviour to shellac's. It is also used to improve the film-forming properties of aqueous shellac dispersions that would otherwise crack. The interaction is physicochemical and specific to the coating solution.

Most probiotic organisms lose viability rapidly at gastric pH, so a coating that stays intact in acid and dissolves higher up the tract is the standard delivery answer. Shellac is one of the resins used for that, though its dissolution pH is less reproducible than a synthetic enteric polymer and drifts with storage age. Survival through a dissolution model is a laboratory measurement, not a count of organisms reaching the colon in a person.

Pancreatic-type enzymes are proteins that lose activity at low pH, and the whole point of an acid-resistant coating on an enzyme product is to keep them folded until the pH rises. Shellac is one of the coating materials used for this. The enabling relationship is a formulation one and is well established in the literature on enteric-coated enzyme products.

Pancreatin contains lipase, amylase and protease activities, of which lipase is the most acid-labile. An acid-resistant film is the standard way of preserving that activity until the preparation reaches a higher pH. The coating choice, shellac or a synthetic polymer, changes the pH and the reproducibility of the release.

Sodium and calcium butyrate are absorbed in the upper tract and carry a distinctive smell, so coatings and lipid matrices are used to carry them further along and to mask odour. Shellac is one of the resins used in that role. Where the material actually releases depends on the film and on transit, which varies between people.

Softgels carrying fish oil are sometimes coated so the shell does not open in the stomach, which is the standard formulation answer to fishy reflux after dosing. Shellac and related resins are used for this. Whether a given coated product actually delays release depends on the coat weight and the resin's condition, which is a dissolution-testing question.

Shellac stays intact because its carboxylic acid groups are protonated and insoluble at low pH. A strongly alkaline core such as a carbonate can raise the microenvironmental pH beneath the film, which works against the acid-resistant behaviour the coating was chosen for. A subcoat is the usual way formulators separate the two.

Bicarbonate raises pH locally and releases carbon dioxide on contact with acid, and a brittle shellac film has little capacity to accommodate internal gas pressure. Both effects work against the integrity of an acid-resistant coating. Where the two must coexist, a barrier subcoat is the conventional answer.

Colloidal silicon dioxide reduces tack and improves bed flow during a coating run, which matters with shellac because the film passes through a sticky stage while the solvent flashes off. It is inert with respect to the resin chemistry. Its role is process control.